DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Gilead Sciences (NASDAQ: GILD)

company name or ticker
Company Photos
(Click to zoom)

Nasdaq 100 Movers: GILD, CELG

Express Scripts CEO: Amgen, Regeneron, Cancer Drugs Next Targets for Drug Discounting

Did Gilead Sciences' Sales Soar in Q4?

Gilead Sciences' fourth quarter and 2015 sales may benefit from an expanding number of people demanding hepatitis C treatment.

Short Interest in Biotechs Signals Optimism

A Look At 3 Biotech Stocks With Upside Potential

Abbvie Retreats On Gilead, Anthem Deal. Buying Opportunity?

Value Investing Strategy For Biotech

3 Stocks Dragging The Drugs Industry Downward

1 Big Loser in the Slugfest Between AbbVie and Gilead Sciences

It's a heavyweight hep-C bout between AbbVie and Gilead Sciences. Who is losing?

Which Big Biotech Will Soar in 2015?

Motley Fool contributors think that Gilead Sciences, Biogen Idec, and Celgene Corp could be top performers in 2015.
See More Articles...